tiprankstipranks
Advertisement
Advertisement

BPTSY Stock Latest News

Biophytis Delays 2025 Annual Results Following €2 Million Refinancing Focus
Company AnnouncementsBiophytis Delays 2025 Annual Results Following €2 Million Refinancing Focus
21d ago
6K
Biophytis Showcases AI-Driven Longevity Drug Discovery with LynxKite at NVIDIA GTC 2026
PremiumCompany Announcements
Biophytis Showcases AI-Driven Longevity Drug Discovery with LynxKite at NVIDIA GTC 2026
2M ago
6K
Biophytis Raises €2 Million, Clears Convertible Debt to Fund Longevity Trials
PremiumCompany Announcements
Biophytis Raises €2 Million, Clears Convertible Debt to Fund Longevity Trials
2M ago
6K
Biophytis Doubles Hexagon Bond Facility to €2 Million and Extends Maturity
PremiumCompany Announcements
Biophytis Doubles Hexagon Bond Facility to €2 Million and Extends Maturity
3M ago
6K
Biophytis Targets Muscle Loss in GLP-1 Weight Loss Users With New Phase 2 Trial
PremiumCompany Announcements
Biophytis Targets Muscle Loss in GLP-1 Weight Loss Users With New Phase 2 Trial
3M ago
BPTSY
Biophytis Strikes Asia Joint Venture and Secures $20 Million to Fund Phase 3 Sarcopenia Trial
PremiumCompany AnnouncementsBiophytis Strikes Asia Joint Venture and Secures $20 Million to Fund Phase 3 Sarcopenia Trial
4M ago
6K
Biophytis Announces Approval of Resolutions at General Meeting
Premium
Company Announcements
Biophytis Announces Approval of Resolutions at General Meeting
6M ago
6K
Biophytis Releases Interim Financial Report for H1 2025
Premium
Company Announcements
Biophytis Releases Interim Financial Report for H1 2025
7M ago
6K
Biophytis Partners with Asian Consortium for Landmark Sarcopenia Trial
PremiumCompany Announcements
Biophytis Partners with Asian Consortium for Landmark Sarcopenia Trial
7M ago
6K
Biophytis Secures Brazilian Funding for Obesity Trial
PremiumCompany Announcements
Biophytis Secures Brazilian Funding for Obesity Trial
8M ago
6K
Biophytis Unveils Phase 3 Sarcopenia Trial Strategy in Europe and Asia
PremiumCompany Announcements
Biophytis Unveils Phase 3 Sarcopenia Trial Strategy in Europe and Asia
8M ago
6K
Biophytis Secures EMA Approval for Phase 2 Obesity Trial
PremiumCompany Announcements
Biophytis Secures EMA Approval for Phase 2 Obesity Trial
9M ago
6K
Biophytis Announces Phase 2 Obesity Trial Strategy for BIO101
PremiumCompany AnnouncementsBiophytis Announces Phase 2 Obesity Trial Strategy for BIO101
9M ago
6K
Biophytis Gains Approval for Phase 3 Sarcopenia Trial
Premium
Company Announcements
Biophytis Gains Approval for Phase 3 Sarcopenia Trial
9M ago
6K
Biophytis Secures Legal Victory in French Court
Premium
Company Announcements
Biophytis Secures Legal Victory in French Court
10M ago
6K
Biophytis Partners with Lynx Analytics to Boost Sarcopenia Drug Discovery
PremiumCompany Announcements
Biophytis Partners with Lynx Analytics to Boost Sarcopenia Drug Discovery
10M ago
6K
Biophytis Showcases BIO101 at World Aging Conference 2025
PremiumCompany Announcements
Biophytis Showcases BIO101 at World Aging Conference 2025
10M ago
6K
Biophytis Announces 2024 Financial Results and Strategic Plans for 2025
PremiumCompany Announcements
Biophytis Announces 2024 Financial Results and Strategic Plans for 2025
10M ago
6K
Biophytis Showcases Innovations at BIO International 2025
PremiumCompany Announcements
Biophytis Showcases Innovations at BIO International 2025
11M ago
6K
Biophytis Delays 2024 Annual Accounts Publication
PremiumCompany AnnouncementsBiophytis Delays 2024 Annual Accounts Publication
11M ago
6K
Biophytis Temporarily Suspends Share Trading Due to Financial Report Delay
Premium
Company Announcements
Biophytis Temporarily Suspends Share Trading Due to Financial Report Delay
11M ago
6K
Biophytis to Showcase Developments at BIO International Convention
Premium
Company Announcements
Biophytis to Showcase Developments at BIO International Convention
12M ago
6K

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >